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Objectives: to determine medium term technical and clinical success of kissing stents for aortoiliac occlusive disease.
Design: retrospective study.
Subjects: twenty-five patients presenting with intermittent claudication (IC) or critical limb ischaemia (CLI) due to aorto-
iliac disease (41 complex stenoses, 8 occlusions).
Methods: balloon- or self-expanding kissing stents, with or without predilatation depending upon the nature of the disease,
were inserted via bilateral retrograde femoral artery punctures. Clinical examination, ABPI, exercise testing and duplex
ultrasound were performed at 1, 3, 6, and 12 months, and then annually.
Results: technical success was achieved in 86% segments. All patients with CLI improved and 6 of 7 ulcerated limbs
showed complete healing. During follow-up, 7 patients died and two patients required major amputation at 7 and 8 months.
The primary assisted patency rate was 94, 91 and 65% at 6, 12, and 24 months, respectively.
Conclusions: despite acceptable short-term technical and clinical success, as the medium term patency rates are clearly
inferior to those of bypass surgery, the kissing stent technique should be reserved for high risk patients with a limited life
expectancy.
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Introduction
The surgical treatment of aortoiliac occlusive disease
is associated with good long-term results and accept-
able mortality (1±3%) and morbidity (5±8%) rates.1
Percutaneous intervention offers a less invasive alter-
native to surgery with a high technical success rates
and comparable long-term results in low-grade TASC
(Trans Atlantic Inter-Society Consensus) lesions.2
However, despite the use of kissing balloons, treat-
ment of aortic bifurcation and iliac origin disease is
associated with a significant risk of dissection, throm-
bosis, and residual stenosis.3,4 For these reasons, the
primary kissing stents technique has been advo-
cated.5,6 However, little is known about the technical
and haemodynamic success of this procedure. Some
authors reporting good and others extremely disap-
pointing outcomes.7±9 The purpose of this study was
to determine the medium term technical and clinical
success rates of kissing stents.
Patients, Methods, and Treatment
Between 1997 and 2000, 25 patients were treated with
kissing stents (Table 1). As one patient had
previously undergone right leg amputation, ABPI
and run-off scores are based 49 limbs. Pre- and post-
interventional angiograms were independently
reviewed by two examiners and lesions classified
Table 1. Baseline characteristics of the study popula-
tion and the preinterventional Fontaine's stage.
Characteristics n (%)
Gender
Male 15 (60)
Female 10 (40)
Risk factors
Diabetes mellitus 4 (16)
Smoking 14 (56)
Hypertension 8 (32)
Hyperlipidaemia 6 (24)
Clinical limb status before intervention
Fontaine's Stage IIb 13 (52)
Fontaine's Stage III 5 (20)
Fontaine's Stage IV 5 (12)
Fontaine's Stage II IV 2 (16)
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according to TASC (Table 2). Technical success rate
was defined as restored patency or 530% residual
diameter stenosis. Clinical success was defined by an
improvement in walking distance (intermittent clau-
dication [CLI]) or an improvement of at least two
Fontaine categories in critical limb ischaemia (CLI).
As patency data from patients who deceased during
the follow-up has been excluded, life table-analysis of
patency is based upon only 36 segments. A 450%
luminal reduction, as indicated by a peak-velocity-
ratio of 42.3 on duplex (3±5 MHz probe, HDI 5000,
ATL Ultrasound Inc., U.S.A.), was considered a sig-
nificant (re)-stenosis.10 Angiography was only repeated
when the patient deteriorated to a point where
re-intervention was being considered. A 470% luminal
reduction on angiography was considered a signi-
ficant (re)-stenosis. A successful haemodynamic
outcome was defined as a 40.15 increase in resting
ABPI or an ABPI 40.9 in the absence of a poor run-
off. Clinical examination, ABPI, exercise testing and
duplex were performed at 1, 3, 6, and 12 months, and
then annually.
Via bilateral retrograde femoral artery punctures, 7
or 8 F sheathes and 0.035-inch hydrophilic guide-
wires (Terumo Corporation, Tokyo, Japan) or a Bentson
guide wire (William Cook, Europe, Bjaeverskov,
Denmark) were placed. In patients with high-grade
stenotic iliac segments predilatation with an under-
sized hydrophilic coated balloon catheter was
performed (Ultra-Thin Diamond Glidex, Boston Scien-
tific Corporation, Watertown, U.S.A.). For severely
calcified lesions balloon expandable stents were used
(Palmaz Stents, Johnson & Johnson). The diameter of
the balloon was equal to that of the native artery.
Balloons were positioned bilaterally and inflated
simultaneously using an inflation device (B. Braun
Medical Inc., Bethlehem, U.S.A.). In patients with
less calcified lesions or elongated arteries self-expand-
ing stents (Wallstent, Boston Scientifc or Smart Stent,
Johnson and Johnson) were deployed simultaneously.
A single stent type and size was used in each indivi-
dual patient. Post-dilations aimed to achieve 510%
stenosis. All patients received acetylsalicylic acid
(100 mg/d) and a bolus of 5000 IU of unfractionated
heparin followed by intravenous infusion of 500 IU/h
for 24 h.
Statistical analysis was performed with the Statistical
Package for Social Sciences (SPSS) for Windows 10.1.3.
Paired t-test was used to analyse normally distributed
continuous data from paired samples. Patency rates
were calculated according to the Kaplan±Meyer life-
table method. Significance niveau was defined as
5 0.05.
Results
Patients presented with IC (n 13), rest pain (n 5), or
non-healing ulcers (n 7). In patients with IC exercise
treatment had either failed or was impossible because
of other limiting disease. Indications for endoluminal,
as opposed to open, treatment were co-morbidity
(n 11), malignancy (n 6), alcoholism (n 2) or
patiens preference (n 5). There were 41 stenoses
and 8 occlusions (Tables 3 and 4). Bilateral common
iliac artery lesions were present in 24 patients. In one
patient, contralateral stenting was necessary for tech-
nical reasons only. In one case, stenting was necessary
because of a dissection during angioplasty. The super-
ficial femoral artery was significantly diseased in 13,
the profunda femoris artery in 2, and both in 2 limbs
(4.1%). All the lesions could be crossed with a wire.
More than one common iliac stent was inserted in
two limbs and in 19 limbs (38.8%) external iliac angio-
plasty or stenting was required.
Technical success was achieved in 43 (86%) seg-
ments. The degree of stenosis reduced significantly
from 75 20 to 17 17% ( p5 0.001) on the right
Table 2. Morphological stratification of iliac
lesions according to the guidelines of the TASC.
TASC type n (%)
A 0
B 2 (8)
C 5 (20)
D 18 (72)
Table 3. Initial stenoses and occlusions of the common and
external iliac arteries.
n (%)
Iliac arteries Right CIA Left CIA Right EIA Left EIA
Initial stenoses
549 1 (4) 4 (16) 2 (8) 1 (4)
50±59 2 (8) 3 (12) 5 (20) 2 (8)
60±69 4 (16) 3 (12) 0 1 (4)
70±79 5 (20) 3 (12) 0 2 (8)
80±89 3 (12) 3 (12) 2 (8) 0
90±99 6 (24) 4 (16) 2 (8) 1 (4)
Occlusion 3 (12) 5 (20) 2 (8) 2 (8)
Total 24 25 13 9
Table 4. Length of initial atherosclerotic lesions of the common
and external iliac arteries.
Right CIA Left CIA Right EIA Left EIA
Length of stenoses (mm)
mean (SD)
25.48
(11.50)
26.36
(24.04)
40.08
(32.35)
39.78
(36.60)
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and from 72+ 22 to 11+14% ( p5 0.001) in the left.
Technical complications occurred in two cases and
resulted in a dissection of the distal aorta, which
needed no additional therapeutic intervention. In
three cases, a common femoral pseudo-aneurysm
had to be treated surgically. The 30-day mortality
rate was 0%.
ABPI increased from 0.69 0.26 to 0.82 0.28
( p 0.003). In 5 patients, ABPI was undetectable
because of severe disease. In all affected patients, rest
pain disappeared soon after the intervention. In 7
patients with ulcers, complete healing occurred in 6
cases and one minor amputation was performed after
one month. In 13 patients with IC, 6 became asymp-
tomatic, walking distance improved in 3 cases, and
2 patients remained unchanged.
There was no major amputation within the first
month after intervention. In one patient, PAD pro-
gressed distally and resulted in a major amputation
8 month after the kissing stent procedure. Another
diabetic patient developed gangrene 7 months after
stenting in combination with contracture of the ipsi-
lateral knee joint followed and required major ampu-
tation. In both cases, kissing stents were patent.
During the follow up period 7 patients died from
cancer (n 3), stroke (n 1), and myocardial infarc-
tion (n 1) or unknown causes (n 2). Deceased
patients were excluded from patency analysis as
patency at time of death was unknown. In 36 limbs,
therefore, followed for a mean of 15.9 9.4 months,
the primary assisted patency rate was 94, 91 and 65%
at 6, 12, and 24 months, respectively (Fig. 1). Three
additional interventions and one thrombectomy for
restenosis were required.
Unilateral significant restenosis was detected in two
segments 12 days and 9 months after the intervention.
The early restenosis due to thrombosis was treated
with thrombectomy. The late stenosis resulted in
re-stenting. Both segments developed a symptomatic
secondary restenosis 10 and 26 months later and were
finally treated by aorto-bifemoral bypass grafting.
In two segments significant stent stenosis occurred
bilaterally 5 and 21 months after intervention. Of
these, one was treated surgically with aorto-bifemoral
bypass grafting, the other was re-stented and devel-
oped a secondary and a tertiary restenosis at 28 and 30
months finally treated by angioplasty. One segment
developed a significant stenosis of one side together
with a contralateral occlusion 22 months after the
primary procedure and was successfully treated by
aorto-bifemoral bypass operation.
Discussion
At first sight kissing stent insertion appears to be an
excellent method for the treatment of proximal iliac
and aortic bifurcation disease. When compared to
open surgery in the short term, iliac stenting appears
to be associated with a similar patency but signif-
icantly less morbidity and mortality.1 However, in
the present series, at 2-years patency had fallen to
65% which is clearly inferior to open surgery. Powell
et al.11 treated comparable disease patterns with
non-kissing stents and reported an assisted primary
patency rate of 72%. Murphy et al.13 reported a 82%
secondary patency rate in their study. By comparison,
surgery is associated with 2-year patency rates of
92±94% (TASC).12
These poor mid-term results are comparable to the
report of Brittenden et al.9 The study group found high
rates of restenosis and occlusions in their series of 12
kissing stents placed for treatment of aortoiliac dis-
ease. More than half of their patients suffered from
symptomatic deterioration within a median range of
27 months. In contrast to our findings, Haulon et al.15
reported on a primary and secondary cumulative
patency at 36 months of 90 and 98% for kissing stents.
Nevertheless, the lesions were not classified according
to the TASC-classification2 and the reconstruction of
the aortic bifurcation was only offered to a highly
selected group making comparison difficult.
Essentially, there seem to be three reasons for the
lower patency rates of kissing stent technique in the 24
months follow-up: First of all, iliac lesions requiring
treatment with kissing stents mostly belong to TASC
Fig. 1. Cumulative primary assisted patency rate performed on 36
limbs (Live Table projection), months, months after procedure,
patency %, percent primary assisted patency rate, at risk, number of
limbs at risk at the end of each period, SE, standard error.
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type D (Figs 2 and 3) as was the case in our study.
Therefore, one could argue that the lesions that neces-
sitate treatment with kissing stents are simply unsuit-
able for endovascular treatment. Secondly, more than
one third of our patients had additional downstream
disease, which could have adversely influenced the
outcome. Thirdly, as suggested by Brittenden et al.
and Salker et al. kissing stents might cause additional
unfavorable flow effects, which could promote intimal
proliferation and thrombus formation.9,14
We conclude from our experience that kissing stent
technique for treatment of complex iliac occlusive dis-
ease should be limited to patients with poor prognosis
due to serious co-morbidity and to those who are
at high risk for surgery. All other cases should be
regarded as candidates for bypass surgery.
Fig. 2. Digital subtraction angiography. (a) complex aortoliliac distal lesion (TASC type D); (b) simultaneous implantation of two stents into
the aortoiliacal bifurcation (kissing stent procedure); (c) post-interventional result.
Fig. 3. Digital subtraction angiography. (a) bilateral aortoiliac lesion (TASC type D); (b) postinterventional result; (c) occlusion of the left
sided stent and restenosis of the right sided stent after 21 months.
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